Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease

Name: Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease
Published: 2007
License: Public Domain

Duke University · 2007

ClinicalTrials.gov · Datasets · License: Public Domain · 2007

Open Source ↗

antigen breast-cancer immunotherapy

breast cancer, immunotherapeutic vaccine, txn2-3m0 breast cancer, metastatic breast cancer, immunotherapy, antigen, histologically confirmed, txn2-3m0 or metastatic breast cancer, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease

Related documents